Difference between revisions of "Yan XP, et al. Oncol. Rep. (2013) cited as Ref 747 in DOI: 10.1038/s41392-020-0110-5 (Q10010)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 30, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 2733-2740, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines (English) | ||
| Property / title: Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 2733-2740 | ||
| Property / Page(s): 2733-2740 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:51, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yan XP, et al. Oncol. Rep. (2013) cited as Ref 747 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yan XP
0 references
2013
0 references
Oncol. Rep.
0 references
30
0 references
Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines (English)
0 references
2733-2740
0 references
